Close Menu

NEW YORK (360Dx) – Singapore cancer diagnostics firm Clearbridge BioMedics said today that it has secured S$6.6 million ($4.8 million) in funding ahead of a planned initial public offering.

According to the company, the round drew interest from both biotech investors, and from medical professionals in the oncology space. Money raised will support Clearbridge's business expansion, technology development, talent recruitment, and expenses related to its potential listing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.